{"status": "OK", "response": {"docs": [{"type_of_material": "Blog", "blog": [], "news_desk": null, "lead_paragraph": "Molecules.", "headline": {"main": "In Wyeth, Pfizer Sees a Drug Pipeline", "kicker": "DealBook"}, "abstract": "Molecules. That's the single word that might best sum up Pfizer's pursuit of Wyeth. Most other traditional big drug companies that have been seen as takeover candidates lately, like Bristol-Myers Squibb and Schering-Plough, still concentrate heavily on so-called small-molecule drugs - medicines made of small chemical molecules and typically dispensed as pills. But about seven [...]", "print_page": null, "word_count": 1093, "_id": "4fd3936b8eb7c8105d8c7070", "snippet": "Molecules. That's the single word that might best sum up Pfizer's pursuit of Wyeth. Most other traditional big drug companies that have been seen as takeover candidates lately, like Bristol-Myers Squibb and Schering-Plough, still concentrate heavily...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://dealbook.nytimes.com/2009/01/27/in-wyeth-pfizer-sees-a-drug-pipeline/", "multimedia": [], "subsection_name": null, "keywords": [{"value": "News", "name": "type_of_material", "rank": "1"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1}], "original": "By DEALBOOK"}, "document_type": "blogpost", "pub_date": "2009-01-27T06:59:48Z", "section_name": "Business Day"}, {"type_of_material": "Obituary", "blog": [], "news_desk": "National", "lead_paragraph": "Mr. Delaney was a prominent advocate for AIDS patients who challenged the government and drug companies to expedite access to experimental treatments in the early days of the epidemic.", "headline": {"main": "Martin Delaney, 63, AIDS Activist, Dies", "print_headline": "Martin Delaney, 63, AIDS Activist"}, "abstract": null, "print_page": "28", "word_count": "440", "_id": "547224987988103bd4a4b09c", "snippet": "Mr. Delaney was a prominent advocate for AIDS patients who challenged the government and drug companies to expedite access to experimental treatments in the early days of the epidemic.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2009/01/27/us/27delaney.html", "multimedia": [{"width": 600, "url": "images/2009/01/27/us/27delaney.600.jpg", "height": 387, "subtype": "xlarge", "legacy": {"xlargewidth": "600", "xlarge": "images/2009/01/27/us/27delaney.600.jpg", "xlargeheight": "387"}, "type": "image"}, {"width": 75, "url": "images/2009/01/27/us/27delaney.75.jpg", "height": 75, "subtype": "thumbnail", "legacy": {"thumbnailheight": "75", "thumbnail": "images/2009/01/27/us/27delaney.75.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"rank": "1", "is_major": "N", "value": "Delaney, Martin", "name": "persons"}, {"rank": "2", "is_major": "N", "value": "Acquired Immune Deficiency Syndrome", "name": "subject"}, {"rank": "3", "is_major": "N", "value": "Medicine and Health", "name": "subject"}, {"rank": "4", "is_major": "N", "value": "Deaths (Obituaries)", "name": "subject"}, {"rank": "5", "is_major": "N", "value": "Drugs (Pharmaceuticals)", "name": "subject"}], "byline": {"contributor": "", "person": [{"organization": "", "role": "reported", "firstname": "Dennis", "rank": 1, "lastname": "HEVESI"}], "original": "By DENNIS HEVESI"}, "document_type": "article", "pub_date": "2009-01-27T00:00:00Z", "section_name": "U.S."}, {"type_of_material": "News", "blog": [], "news_desk": "Science", "lead_paragraph": "The hygiene hypothesis suggests that organisms that enter the body along with \u201cdirt\u201d spur the development of a healthy immune system.", "headline": {"main": "Babies Know: A Little Dirt Is Good for You", "kicker": "Personal Health", "print_headline": "Babies Know: A Little Dirt Is Good for You", "content_kicker": "Personal Health"}, "abstract": null, "print_page": "7", "word_count": "1127", "_id": "54721ead7988103bd4a4b01a", "snippet": "The hygiene hypothesis suggests that organisms that enter the body along with \u201cdirt\u201d spur the development of a healthy immune system.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2009/01/27/health/27brod.html", "multimedia": [{"width": 600, "url": "images/2009/01/27/health/27brody.lg.jpg", "height": 975, "subtype": "xlarge", "legacy": {"xlargewidth": "600", "xlarge": "images/2009/01/27/health/27brody.lg.jpg", "xlargeheight": "975"}, "type": "image"}, {"width": 75, "url": "images/2009/01/27/health/27brod75.jpg", "height": 75, "subtype": "thumbnail", "legacy": {"thumbnailheight": "75", "thumbnail": "images/2009/01/27/health/27brod75.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"rank": "1", "is_major": "N", "value": "Medicine and Health", "name": "subject"}, {"rank": "3", "is_major": "N", "value": "Immune System", "name": "subject"}, {"rank": "4", "is_major": "N", "value": "Babies", "name": "subject"}, {"rank": "5", "is_major": "N", "value": "Allergies", "name": "subject"}, {"rank": "6", "is_major": "N", "value": "Digestive Tract", "name": "subject"}, {"rank": "7", "is_major": "N", "value": "Bacteria", "name": "subject"}], "byline": {"person": [{"firstname": "Jane", "middlename": "E.", "lastname": "BRODY", "rank": 1, "role": "reported", "organization": ""}], "original": "By JANE E. BRODY"}, "document_type": "article", "pub_date": "2009-01-27T00:00:00Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": "Business", "lead_paragraph": "Pfizer\u2019s planned acquisition of Wyeth is a validation of Wyeth\u2019s decision to reduce its reliance on small-molecule drugs.", "headline": {"seo": "In Wyeth, Pfizer Saw a Promise of Biological Drugs", "main": "In Wyeth, Pfizer Sees a Drug Pipeline", "print_headline": "In Pursuit of a Pipeline of Biological Treatments"}, "abstract": null, "print_page": "4", "word_count": "1096", "_id": "54721f9a7988103bd4a4b02d", "snippet": "Pfizer\u2019s planned acquisition of Wyeth is a validation of Wyeth\u2019s decision to reduce its reliance on small-molecule drugs.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2009/01/27/business/27wyeth.html", "multimedia": [{"subtype": "thumbnail", "url": "images/2009/01/27/business/27pfizer.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2009/01/27/business/27pfizer.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "Wyeth", "is_major": "N", "rank": "1", "name": "organizations"}, {"value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "Mergers, Acquisitions and Divestitures", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "Biotechnology", "is_major": "N", "rank": "4", "name": "subject"}, {"value": "Pfizer Inc", "is_major": "N", "rank": "5", "name": "organizations"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Natasha", "lastname": "SINGER"}], "original": "By NATASHA SINGER"}, "document_type": "article", "pub_date": "2009-01-27T00:00:00Z", "section_name": "Business Day"}, {"type_of_material": "Blog", "blog": [], "news_desk": null, "lead_paragraph": "Note: This lesson was originally published on an older version of The Learning Network; the link to the related Times article will take you to a page on the old site.", "headline": {"main": "Kiss and Tell", "kicker": "The Learning Network"}, "abstract": "In this lesson, students conduct an online scavenger hunt about mononucleosis, sometimes called the \"kissing\" disease, using the New York Times \"Times Essentials: Reporter's File\" health resource. Then, students create additional articles, graphics or interactive features about mono to add to the Reporter's File.", "print_page": null, "word_count": 1059, "_id": "4fd3936b8eb7c8105d8c7089", "snippet": "In this lesson, students conduct an online scavenger hunt about mononucleosis, sometimes called the \"kissing\" disease, using the New York Times \"Times Essentials: Reporter's File\" health resource. Then, students create additional articles, graphics...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://learning.blogs.nytimes.com/2009/01/27/kiss-and-tell/", "multimedia": [], "subsection_name": null, "keywords": [{"value": "News", "name": "type_of_material", "rank": "1"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Catherine", "lastname": "HUTCHINGS"}], "original": "By CATHERINE HUTCHINGS"}, "document_type": "blogpost", "pub_date": "2009-01-27T00:00:00Z", "section_name": "U.S."}, {"type_of_material": "Op-Ed", "blog": [], "news_desk": "Editorial", "lead_paragraph": "A peek into Bill Gates\u2019s letter. He\u2019s not only going to do more for health and development in the poorest nations and education in America, he is calling for your help, too.", "headline": {"main": "Bill Gates\u2019s Next Big Thing", "kicker": "Op-Ed Columnist", "print_headline": "Bill Gates\u2019s Next Big Thing", "content_kicker": "Op-Ed Columnist"}, "abstract": null, "print_page": "12", "word_count": "811", "_id": "53f599277988107411a38b83", "snippet": "A peek into Bill Gates\u2019s letter. He\u2019s not only going to do more for health and development in the poorest nations and education in America, he is calling for your help, too.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2009/01/25/opinion/25kristof.html", "multimedia": [{"width": 190, "url": "images/2010/09/16/opinion/Kristof_New/Kristof_New-thumbWide-v2.jpg", "height": 126, "subtype": "wide", "legacy": {"wide": "images/2010/09/16/opinion/Kristof_New/Kristof_New-thumbWide-v2.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"width": 600, "url": "images/2010/09/16/opinion/Kristof_New/Kristof_New-articleLarge.jpg", "height": 766, "subtype": "xlarge", "legacy": {"xlargewidth": "600", "xlarge": "images/2010/09/16/opinion/Kristof_New/Kristof_New-articleLarge.jpg", "xlargeheight": "766"}, "type": "image"}, {"width": 75, "url": "images/2006/04/02/opinion/ts-kristof-75.jpg", "height": 75, "subtype": "thumbnail", "legacy": {"thumbnailheight": "75", "thumbnail": "images/2006/04/02/opinion/ts-kristof-75.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"rank": "1", "is_major": "N", "value": "Gates, Bill", "name": "persons"}, {"rank": "2", "is_major": "N", "value": "Gates, Bill and Melinda, Foundation", "name": "organizations"}, {"rank": "3", "is_major": "N", "value": "Education and Schools", "name": "subject"}, {"rank": "4", "is_major": "N", "value": "Medicine and Health", "name": "subject"}, {"rank": "5", "is_major": "N", "value": "Vaccination and Immunization", "name": "subject"}, {"rank": "6", "is_major": "N", "value": "Economic Conditions and Trends", "name": "subject"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Nicholas", "rank": 1}], "original": "By NICHOLAS D. KRISTOF"}, "document_type": "article", "pub_date": "2009-01-25T00:00:00Z", "section_name": "Opinion"}, {"type_of_material": "News", "blog": [], "news_desk": "National", "lead_paragraph": "Research has linked contaminants to diseases, but that often fails to help victims win worker\u2019s compensation.", "headline": {"main": "Exposed to Solvent, Worker Faces Hurdles", "sub": "No Compensation for Health Issues;", "print_headline": "Exposed to Solvent, Worker Faces Hurdles"}, "abstract": null, "print_page": "16", "word_count": "1283", "_id": "547214a87988103bd4a4af34", "snippet": "Research has linked contaminants to diseases, but that often fails to help victims win worker\u2019s compensation.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2009/01/25/us/25toxic.html", "multimedia": [{"width": 75, "url": "images/2009/01/25/us/24toxic_75.jpg", "height": 75, "subtype": "thumbnail", "legacy": {"thumbnailheight": "75", "thumbnail": "images/2009/01/25/us/24toxic_75.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"rank": "1", "is_major": "N", "value": "Hazardous and Toxic Substances", "name": "subject"}, {"rank": "2", "is_major": "N", "value": "Workers' Compensation Insurance", "name": "subject"}, {"rank": "3", "is_major": "N", "value": "Medicine and Health", "name": "subject"}, {"rank": "4", "is_major": "N", "value": "Labor", "name": "subject"}, {"rank": "5", "is_major": "N", "value": "Parkinson's Disease", "name": "subject"}, {"rank": "6", "is_major": "N", "value": "Dresser Industries", "name": "organizations"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Felicity", "rank": 1, "lastname": "BARRINGER"}], "original": "By FELICITY BARRINGER"}, "document_type": "article", "pub_date": "2009-01-25T00:00:00Z", "section_name": "U.S."}, {"type_of_material": "News", "blog": [], "news_desk": "Regionals", "lead_paragraph": "A soap-opera style project is designed to change attitudes about safe sex among young women.", "headline": {"seo": "A Soap Opera Aims to Fight H.I.V./AIDS", "main": "A Soap Opera\u2019s Sex Is All for a Good Cause", "kicker": "Health | Jersey City", "print_headline": "A Soap Opera\u2019s Sex Is All for a Good Cause", "content_kicker": "Health | Jersey City"}, "abstract": null, "print_page": "6", "word_count": "627", "_id": "54720062798810704647800b", "snippet": "A soap-opera style project is designed to change attitudes about safe sex among young women.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2009/01/25/nyregion/new-jersey/25soapnj.html", "multimedia": [{"width": 600, "url": "images/2009/01/25/nyregion/25soapnj.span.jpg", "height": 348, "subtype": "xlarge", "legacy": {"xlargewidth": "600", "xlarge": "images/2009/01/25/nyregion/25soapnj.span.jpg", "xlargeheight": "348"}, "type": "image"}, {"width": 75, "url": "images/2009/01/25/nyregion/25soapnj.75.jpg", "height": 75, "subtype": "thumbnail", "legacy": {"thumbnailheight": "75", "thumbnail": "images/2009/01/25/nyregion/25soapnj.75.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": "New Jersey", "keywords": [{"rank": "1", "is_major": "N", "value": "Sexually Transmitted Diseases", "name": "subject"}, {"rank": "2", "is_major": "N", "value": "Women", "name": "subject"}, {"rank": "3", "is_major": "N", "value": "Medicine and Health", "name": "subject"}, {"rank": "4", "is_major": "N", "value": "New Jersey", "name": "glocations"}], "byline": {"person": [{"firstname": "Jennifer", "middlename": "V.", "lastname": "HUGHES", "rank": 1, "role": "reported", "organization": ""}], "original": "By JENNIFER V. HUGHES"}, "document_type": "article", "pub_date": "2009-01-25T00:00:00Z", "section_name": "N.Y. / Region"}, {"type_of_material": "News", "blog": [], "news_desk": "Business", "lead_paragraph": "The government will allow the world\u2019s first test in people of a therapy derived from human embryonic stem cells.", "headline": {"seo": "F.D.A. Approves a Stem Cell Trial", "main": "F.D.A. Approves a Stem Cell Trial", "print_headline": "Milestone In Research In Stem Cells"}, "abstract": null, "print_page": "1", "word_count": "1350", "_id": "5472061a7988107046478086", "snippet": "The government will allow the world\u2019s first test in people of a therapy derived from human embryonic stem cells.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2009/01/23/business/23stem.html", "multimedia": [{"width": 75, "url": "images/2009/01/23/business/23stem01-75.jpg", "height": 75, "subtype": "thumbnail", "legacy": {"thumbnailheight": "75", "thumbnail": "images/2009/01/23/business/23stem01-75.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"rank": "1", "is_major": "N", "value": "Stem Cells", "name": "subject"}, {"rank": "2", "is_major": "N", "value": "Medicine and Health", "name": "subject"}, {"rank": "3", "is_major": "N", "value": "Food and Drug Administration", "name": "organizations"}, {"rank": "4", "is_major": "N", "value": "Tests and Testing", "name": "subject"}, {"rank": "5", "is_major": "N", "value": "Obama, Barack", "name": "persons"}, {"rank": "6", "is_major": "N", "value": "Paralysis", "name": "subject"}, {"rank": "7", "is_major": "N", "value": "Geron Corporation", "name": "organizations"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Andrew", "rank": 1, "lastname": "POLLACK"}], "original": "By ANDREW POLLACK"}, "document_type": "article", "pub_date": "2009-01-23T00:00:00Z", "section_name": "Business Day"}], "meta": {"hits": 9, "offset": 0, "time": 50}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}